BioCentury | Oct 31, 2018
Distillery Techniques

Imaging; other

...93.9% specificity, compared with 80.8% sensitivity and 87.5% specificity without the model. Next steps by Imagen...
...Oct. 22, 2018 doi:10.1073/pnas.1806905115 CONTACT: Robert Lindsey, Imagen Technologies Inc., New York, N.Y. email: rob@imagen.ai Claire Quang Imagen...
BioCentury | Jun 1, 2018
Clinical News

AI-based diagnostic for wrist fractures gets FDA green light

...FDA has permitted marketing of OsteoDetect, an artificial intelligence-based software product from Imagen Technologies Inc. (New...
...of Clinical Oncology (ASCO) meeting in Chicago, Gottlieb said in a tweet on May 25. Imagen...
BioCentury | May 25, 2018
Company News

AI-based diagnostic for wrist fractures gets FDA green light

...FDA has permitted marketing of OsteoDetect, an artificial intelligence-based software product from Imagen Technologies (New York...
...American Society of Clinical Oncology (ASCO) meeting in Chicago, Gottlieb said in a tweet Friday. Jennie Walters Imagen OsteoDetect...
BioCentury | Jul 14, 2014
Company News

Applied Genetic Technologies Corp management update

...NASDAQ:AGTC), Alachua, Fla. Business: Gene/Cell therapy Hired: Matthew Feinsod, founder and formerly CMO of Imagen...
BioCentury | Mar 10, 2014
Finance

Innovator capital rationing

Conventional wisdom says VCs don't fund research-stage companies, but the numbers - and investors who play in the space - tell a different story. Since the financial meltdown, companies with a lead program in discovery or preclinical...
BioCentury | Oct 24, 2011
Financial News

Imagen completes venture financing

Imagen Biotech Inc. , New York, N.Y. Business: Ophthalmic Date completed: 10/19/11 Type: Venture financing Raised: Not disclosed Investors: SV Life Sciences; Novo Ventures; Fidelity Biosciences Note: The company said it secured up to $40 million...
BioCentury | Oct 20, 2011
Financial News

Imagen eyes $40 million A round

...Newco Imagen Biotech Inc. (New York, N.Y.) said it secured up to $40 million in a...
...million in a series A round from SV Life Sciences; Novo Ventures; and Fidelity Biosciences. Imagen...
...this summer by ophthalmologists David Guyer and Matthew Feinsod. Guyer, who is executive chairman of Imagen...
BioCentury | Dec 6, 2010
Company News

imaGenes, Source BioScience plc deal

Source BioScience acquired imaGenes for £2 million ($3.1 million) in cash. imaGenes, which provides services including sequencing, expression profiling and protein assays, had 2009 sales of £2.5 million ($4 million). Source BioScience said the acquisition...
BioCentury | Apr 23, 2007
Finance

Ebb & Flow

Gilead (GILD) gave the Street another upside surprise for the first quarter, but the EPS uplift looks to have come from less spending on R&D, rather than unexpectedly high revenue. Indeed, while GILD's quarterly revenue...
BioCentury | Apr 19, 2007
Financial News

aTyr raises $10.5 million

aTyr (San Diego, Calif.) raised $10.5 million in a series B round co-led by new investors Alta Partners and Polaris Venture Partners. Imagene, another new investor, and founding investor Cardinal Partners also participated. The company...
Items per page:
1 - 10 of 14
BioCentury | Oct 31, 2018
Distillery Techniques

Imaging; other

...93.9% specificity, compared with 80.8% sensitivity and 87.5% specificity without the model. Next steps by Imagen...
...Oct. 22, 2018 doi:10.1073/pnas.1806905115 CONTACT: Robert Lindsey, Imagen Technologies Inc., New York, N.Y. email: rob@imagen.ai Claire Quang Imagen...
BioCentury | Jun 1, 2018
Clinical News

AI-based diagnostic for wrist fractures gets FDA green light

...FDA has permitted marketing of OsteoDetect, an artificial intelligence-based software product from Imagen Technologies Inc. (New...
...of Clinical Oncology (ASCO) meeting in Chicago, Gottlieb said in a tweet on May 25. Imagen...
BioCentury | May 25, 2018
Company News

AI-based diagnostic for wrist fractures gets FDA green light

...FDA has permitted marketing of OsteoDetect, an artificial intelligence-based software product from Imagen Technologies (New York...
...American Society of Clinical Oncology (ASCO) meeting in Chicago, Gottlieb said in a tweet Friday. Jennie Walters Imagen OsteoDetect...
BioCentury | Jul 14, 2014
Company News

Applied Genetic Technologies Corp management update

...NASDAQ:AGTC), Alachua, Fla. Business: Gene/Cell therapy Hired: Matthew Feinsod, founder and formerly CMO of Imagen...
BioCentury | Mar 10, 2014
Finance

Innovator capital rationing

Conventional wisdom says VCs don't fund research-stage companies, but the numbers - and investors who play in the space - tell a different story. Since the financial meltdown, companies with a lead program in discovery or preclinical...
BioCentury | Oct 24, 2011
Financial News

Imagen completes venture financing

Imagen Biotech Inc. , New York, N.Y. Business: Ophthalmic Date completed: 10/19/11 Type: Venture financing Raised: Not disclosed Investors: SV Life Sciences; Novo Ventures; Fidelity Biosciences Note: The company said it secured up to $40 million...
BioCentury | Oct 20, 2011
Financial News

Imagen eyes $40 million A round

...Newco Imagen Biotech Inc. (New York, N.Y.) said it secured up to $40 million in a...
...million in a series A round from SV Life Sciences; Novo Ventures; and Fidelity Biosciences. Imagen...
...this summer by ophthalmologists David Guyer and Matthew Feinsod. Guyer, who is executive chairman of Imagen...
BioCentury | Dec 6, 2010
Company News

imaGenes, Source BioScience plc deal

Source BioScience acquired imaGenes for £2 million ($3.1 million) in cash. imaGenes, which provides services including sequencing, expression profiling and protein assays, had 2009 sales of £2.5 million ($4 million). Source BioScience said the acquisition...
BioCentury | Apr 23, 2007
Finance

Ebb & Flow

Gilead (GILD) gave the Street another upside surprise for the first quarter, but the EPS uplift looks to have come from less spending on R&D, rather than unexpectedly high revenue. Indeed, while GILD's quarterly revenue...
BioCentury | Apr 19, 2007
Financial News

aTyr raises $10.5 million

aTyr (San Diego, Calif.) raised $10.5 million in a series B round co-led by new investors Alta Partners and Polaris Venture Partners. Imagene, another new investor, and founding investor Cardinal Partners also participated. The company...
Items per page:
1 - 10 of 14